About RBC Life Sciences
RBC Life Sciences, Inc. is engaged in the marketing of nutritional supplements and personal care products through subsidiaries in North America and Southeast Asia and through licensees in Russia/Eastern Europe. The Company's segments include Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in over three categories: wellness products, fitness products and personal care products. Its Medical Products segment distributes wound care products. Nutritional Products are marketed under the RBC Life brand name. As of September 30, 2015, its Nutritional Products segment manufactured and distributed a line of over 100 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. As of September 30, 2015, it marketed a line of over 35 wound care products under the MPM Medical brand name through a subsidiary operating primarily in the United States.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Exchange: OTCMKTS
- Symbol: RBCL
Companies Related to RBC Life Sciences:
- Previous Close: $0.00
- 50 Day Moving Average: $
- 200 Day Moving Average: $
- 52-Week Range: $2,212,000.00 - $0.10
- Trailing P/E Ratio:
- P/E Growth:
- Market Cap: $
- Outstanding Shares: 2,212,000
- Beta: -0.54
Consensus Ratings for RBC Life Sciences (OTCMKTS:RBCL) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for RBC Life Sciences (OTCMKTS:RBCL)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for RBC Life Sciences (OTCMKTS:RBCL)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for RBC Life Sciences (OTCMKTS:RBCL)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for RBC Life Sciences (OTCMKTS:RBCL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for RBC Life Sciences (OTCMKTS:RBCL)
Insider Ownership Percentage: 45.80%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|6/16/2014||Clinton H Howard||CEO||Buy||5,000||$0.60||$3,000.00|| |
|6/2/2014||Clinton H Howard||CEO||Buy||3,100||$0.60||$1,860.00|| |
Headlines for RBC Life Sciences (OTCMKTS:RBCL)
No headlines for this company have been tracked by MarketBeat.com
What is RBC Life Sciences' stock symbol?
RBC Life Sciences trades on the OTCMKTS under the ticker symbol "RBCL."
How do I buy RBC Life Sciences stock?
Shares of RBC Life Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of RBC Life Sciences stock cost?
One share of RBC Life Sciences stock can currently be purchased for approximately $0.35.
RBC Life Sciences (OTCMKTS:RBCL) Chart for Monday, February, 27, 2017
Institutional Ownership ChartEarnings History ChartDividend History Chart